Skip to main content

Newly diagnosed and patient monitoring

Stay on track with type 2 diabetes testing

The Quest Diagnostics Diabetes, Newly Diagnosed and Monitoring Panel offers you a simple way to follow American Diabetes Association (ADA) recommendations for diabetes lab testing in patients with type 2 diabetes.1 Using this single panel that adheres to testing guidelines, you’ll be able to detect the onset of complications as early as possible and make informed decisions about how to proceed with treatment.

The Diabetes, Newly Diagnosed and Monitoring Panel assesses:

  • Fasting lipid levels
  • Fasting glucose
  • HbA1c
  • Liver function tests (albumin, total and direct bilirubin, alkaline phosphatase, total protein, ALT, AST)
  • Urinary albumin excretion (UAE)
  • Spot urine albumin-to-creatinine ratio
  • Serum creatinine/eGFR

    Use the Diabetes, Newly Diagnosed and Monitoring Panel as part of your routine annual visit to get a baseline snapshot of key parameters in newly diagnosed patients.

Newly diagnosed and patient monitoring tests

This information is provided for informational purposes only and is not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.


1. Standards of medical care in diabetes—2017. Diabetes Care. 2017;40(Suppl 1):S1-S135. doi:0.2337/dc17-S003

During the COVID-19 health crisis, fast action and trusted information matter more than ever.

Find out what's happening

Learn More